Detalhe da pesquisa
1.
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial.
Trials
; 21(1): 981, 2020 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33246499
2.
Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial.
Trials
; 21(1): 1024, 2020 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33317581
3.
Can non-physician health-care workers assess and manage cardiovascular risk in primary care?
Bull World Health Organ
; 85(6): 432-40, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17639240
4.
Can non-physician health-care workers assess and manage cardiovascular risk in primary care?
Bull. W.H.O. (Print)
; 85(6): 432-440, 2007-6.
Artigo
em Inglês
| WHOLIS | ID: who-269956